A randomized, double-blind, controlled trial to assess the effects of lactoferrin at two doses vs. active control on immunological and safety parameters in healthy adults

Clinical Trial Results
Written by Emily Hoelscher

Peterson RD, Guarneiri LL, Adams CG, Wilcox ML, Clark AJ, Rudemiller NP, Maki KC, Malinczak CA. A randomized, double-blind, controlled trial to assess the effects of lactoferrin at two doses vs. active control on immunological and safety parameters in healthy adults. Int J Toxicol. 2025;44:12-28.

Read Full Publication →

Emily Hoelscher
Previous

Perspective on the health effects of unsaturated fatty acids and commonly consumed plant oils high in unsaturated fat
Next

The role of nutrition-related clinical trials in informing dietary recommendations for health and treatment of diseases